Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Asset Utilization Ratio: 2014-2025

Historic Asset Utilization Ratio for Fennec Pharmaceuticals (FENC) over the last 5 years, with Sep 2025 value amounting to 0.82.

  • Fennec Pharmaceuticals' Asset Utilization Ratio rose 1.94% to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year increase of 1.94%. This contributed to the annual value of 1.32 for FY2024, which is 67.60% up from last year.
  • Fennec Pharmaceuticals' Asset Utilization Ratio amounted to 0.82 in Q3 2025, which was up 12.94% from 0.73 recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' Asset Utilization Ratio peaked at 0.94 during Q1 2024, and registered a low of -0.04 during Q4 2022.
  • In the last 3 years, Fennec Pharmaceuticals' Asset Utilization Ratio had a median value of 0.74 in 2024 and averaged 0.66.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Asset Utilization Ratio tumbled by 357.71% in 2022 and then soared by 4,380.41% in 2023.
  • Fennec Pharmaceuticals' Asset Utilization Ratio (Quarterly) stood at 0.00 in 2021, then slumped by 357.71% to -0.04 in 2022, then skyrocketed by 2,366.74% to 0.91 in 2023, then rose by 0.88% to 0.92 in 2024, then climbed by 1.94% to 0.82 in 2025.
  • Its Asset Utilization Ratio stands at 0.82 for Q3 2025, versus 0.73 for Q2 2025 and 0.68 for Q1 2025.